Global Ion-Selective Clinical Lab
Analyzers Market Drivers
Leading manufacturers in the
global Ion-Selective
Clinical Lab Analyzers Market are focused on the development of products.
For instance, Erba Mannheim launched EC90, a new electrolyte analyzer in
February 2020 at the MEDLAB Middle East trade fair. The EC90 analyzer contains
maintenance free electrode, cleaning of the pack is not required, and waste is
self-contained. Moreover, it can analyze samples in 35 seconds.
In 2017, Beckman Coulter
Diagnostics, announced the U.S. Food & Drug Administration (FDA) approval
and commercial launch of its new DxC 700 AU chemistry analyzer in the U.S. The
analyzer has combined features of two Beckman Coulter products; DxC analyzer
and AU analyzer. Moreover, the system also uses concentrated reagents, ISEs which
are long lasting, and non-disposable cuvettes. Horiba, Ltd received premarket
notification for marketing Yumizen C1200, in 2019. Yumizen C1200 is an
automatic chemical analyzer that measures analytes in samples, in combination
with reagents, calibrators, quality control (QC) material and other
accessories. It consists of glucose HK, sodium electrode, potassium electrode,
and chloride electrode. The device is useful in the diagnosis of levels of
sodium, potassium and chloride in blood and urine samples.
Other advantages of using ion
selective electrodes over other methods are that they can be used for a sample
size of 0.1 to 10,000 ppm. Moreover, they are shock-proof and
chemical-resistant, upon calibration, and one can monitor concentration
continuously and analyze the sample within 1 to 2 minutes. The above factors
are expected to drive the global ion selective clinical lab analyzers market
growth over the forecast period.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3461
An ion selective analyzer
comprises of ion selective electrode (ISE) and is an analytical technique used
to determine the activity of ions in aqueous solution by measuring the
electrical potential. It has application in the field of pharmaceuticals and
biotechnology. There are four types of ISE glass electrode, crystalline
electrodes, ion-exchange electrodes, and enzyme electrodes. A common example of
ISE is the pH Electrode. The pH electrode is the commonly used and it consists
of a thin glass membrane which calculates the H+ concentration in a solution.
Orion Versa Star Pro pH/ISE is an example of ISE and is manufactured by Thermo
Fisher Scientific Inc. It is used for the measurement of routine pH and ion
concentration.
Moreover, Beckman Coulter, Inc.
manufactures and markets reagents such as buffer, high/low serum standard,
high/low urine standard, internal reference solution and Na+ /K+ selectivity
check solution for the quantitative determination of sodium, potassium and
chloride concentrations in human serum and urine on the Beckman Coulter ISE
modules. Some of the other manufacturers are Van London Company, Abbott Point
of Care Inc., and others.
Global Ion-Selective Clinical Lab
Analyzers Market Restraints
Manufacturers are focused on
modifying conventional ISE in order to reduce the drawbacks of the technique
which include the selective membrane used in the ISE, which can allow the entry
of more than one type of ion at a time, and the electrodes have to be replaced
periodically. Moreover, ISE calculates ions when they move across the membrane.
In case of dilute solution the number of ions near the membrane would be less
than the ions present in the bulk solution. Therefore, the membrane potential
recorded may get altered in both the cases.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/ion-selective-clinical-lab-analyzers-market-3461
Global Ion-Selective Clinical Lab
Analyzers Market Regional Analysis
North America is expected to
dominate the global ion-selective clinical lab analyzers market over the
forecast period as manufacturers are focused on the development and
introduction of ion selective clinical lab analyzers in the North American
region. For instance, Thermo Fisher Scientific Inc. launched a premium Thermo
Scientific Orion Ammonia Ion Selective Electrode in 2018. The new electrode can
detect ions in low concentration as it is sensitive to ions and requires less
electrode maintenance. It is an ideal product to use in drinking water and
wastewater laboratories.
Moreover, Beckman Coulter
Diagnostics received U.S. FDA approval for its DxC 700 AU Chemistry Analyzer in
2017. The DxC 700 AU system was initially available in the U.S. before 2017.
Abbott Point of Care Inc.'s product i-STAT which is a handheld device, can
perform blood analysis in four steps. The advantage of i-STAT over benchtop
analyzers is that it provides faster results. The above factors are expected to
boost the global ion – selective clinical lab analyzers market growth over the
forecast period.
Global Ion- Selective Clinical Lab
Analyzers Market Key Players
Some of the key players operating
in the global ion–selective clinical lab analyzers market are Thermo Fisher
Scientific Inc., Van London Company, Abbott Point of Care Inc., Beckman
Coulter, Inc., Diagnostika Pilipinas Inc. F. Hoffmann-La Roche Ltd, ECD, Alfa
Wassermann Inc., Pointe Scientific, Inc., Metrohm AG, and Medica Corporation.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3461
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment